New Horizon Health (HKSE:06606) FCF Yield % : -10.94 (As of Jun. 06, 2024)

View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, New Horizon Health's Trailing 12-Month Free Cash Flow is HK$-694 Mil, and Market Cap is HK$6,345 Mil. Therefore, New Horizon Health's FCF Yield % for today is -10.94%.

The historical rank and industry rank for New Horizon Health's FCF Yield % or its related term are showing as below:

HKSE:06606' s FCF Yield % Range Over the Past 10 Years
Min: -10.94 Med: -5.23 Max: -0.52
Current: -10.94

During the past 5 years, the highest FCF Yield % of New Horizon Health was -0.52%. The lowest was -10.94%. And the median was -5.23%.

HKSE:06606's FCF Yield % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -2.74 vs HKSE:06606: -10.94

New Horizon Health's FCF Margin % for the quarter that ended in Jun. 2023 was -51.43%.

New Horizon Health FCF Yield % Historical Data

The historical data trend for New Horizon Health's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health FCF Yield % Chart

New Horizon Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Yield %

-5.05

-6.88

New Horizon Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Yield %	Get a 7-Day Free Trial				-1.07	-6.21	-6.00	-6.11	-7.40

Competitive Comparison of New Horizon Health's FCF Yield %

For the Medical Devices subindustry, New Horizon Health's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

New Horizon Health's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's FCF Yield % distribution charts can be found below:

* The bar in red indicates where New Horizon Health's FCF Yield % falls into.

New Horizon Health FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

New Horizon Health's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-520.809	/	7568.0352
	=	-6.88%

New Horizon Health's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-462.787	*	2	/	12515.38735
	=	-7.40%

New Horizon Health FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

New Horizon Health FCF Yield % Related Terms

Thank you for viewing the detailed overview of New Horizon Health's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

New Horizon Health (HKSE:06606) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

6YZ:Germany

Address

400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

https://ir.newhorizonbio.com

New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

Executives

Invesco Advisers, Inc.	2102 Investment manager
Chen Yiyou	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Bancasa Holding Limited	2201 Interest of corporation controlled by you
Mst Development Limited	2101 Beneficial owner
Yao Naxin	2305 Beneficiary of a trust
Janus Henderson Group Plc	2102 Investment manager
Jpmorgan Chase & Co.	2106 Person having a security interest in shares
Invesco Developing Markets Fund	2106 Person having a security interest in shares
Zhu Yeqing	2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines